NCT00482807View on ClinicalTrials.gov

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

March 9, 2010

Study Completion Date

March 9, 2010

Conditions
Prostate Cancer
Interventions
DRUG

bicalutamide

DRUG

docetaxel

DRUG

goserelin

RADIATION

intensity-modulated radiation therapy

Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Nebraska

OTHER

NCT00482807 - Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer | Biotech Hunter | Biotech Hunter